Abstract:Alzheimer’s disease (AD) is a progressive neurodegenerative disease that produces disturbances in memory and learning eventually leading to dementia. Responsible for two-thirds of the total cases of dementia in the United States, AD will claim between 3 and 4 million victims by the year 2030 at the present rates of incidence and prevalence. The disease presents with a variable course that ranges from a few years to decades, but which invariably ends in death. Current estimates indicate that over half of the available nursing home beds in this country are now occupied by patients with AD, and the associated economic costs of this disease are staggering. These costs do not consider the emotional toll of the disease on the survivors and caregivers who must witness the slowly vanishing personality and intellect of a family member or close friend. No truly effective treatment exists for this disease although one drug has been approved by the Food and Drug Administration and several more are in clinical trials. Many years of effort and several hundred millions of dollars have been spent researching the causes of AD, and much has been learned in the last 20 years; however, the specific etiology of even one of the many possible forms of AD remains unknown. Approximately 10-15% of clinical cases of AD are of the familial form which has an onset as early as the fourth decade and often has a more rapid course than the non-familial or sporadic type that represents the majority of AD cases and usually has a later age of onset in the sixth and seventh decades. Several genetic loci have now been identified for variants of the familial form of the disease, and the e4 allele of the gene encoding the apolipoprotein E molecule has now been shown to be associated with the late-onset form of AD. What remains unknown is whether and how these genetically different forms of the disease have the same profile of neurochemical deficits during the course of the disease. This is important becauseuntil the molecular precipitant of the disease process(es) is identified and a strategy developed to combat it, a rational treatment of the existing population of patients should be directed toward normalization of the existing neurochemical alterations. Unfortunately, the available research materials do not give a clear or consistent picture of the course of AD in terms of the neurochemical changes at different stages of the disease. These research materials usually take two forms: (1) the postmortem brain from a patient with a clinical history of dementia and neuropathologically confirmed

Linear Sweep Voltammetric Detection of Serum Albumin with Chromotrope 2B

Quantitation, Visualization, and Monitoring of Conformational Transitions of Human Serum Albumin by A Tetraphenylethene Derivative with Aggregation-Induced Emission Characteristics

Pre-Operative, High-IL-6 Blood Level is a Risk Factor of Post-Operative Delirium Onset in Old Patients

A supramolecular ratiometric fluorescent probe for the detection of human serum albumin

A microenvironment-sensitive red emissive probe with a large Stokes shift for specific recognition and quantification of serum albumin in complex biofluids and live cells

Bimodal Turn‐On Fluorescent Probe for Photophysical and Electrochemical Detection of Human Serum Albumin in Clinical Samples

Neuropeptides and Alzheimer's Disease Pathology

Facile, Sensitive and Selective Fluorescence Turn-on Detection of HSA/BSA in Aqueous Solution Utilizing 2,4-Dihydroxyl-3-iodo Salicylaldehyde Azine

Time-resolved fluorescence determination of albumin using ZnGeO:Mn luminescence nanorods modified with polydopamine nanoparticles

Detection and quantification of urine albumin using a miniature colorimetric sensor consisting of UVC LEDs and CsPbBr3 quantum dot color converters

Detection of human serum albumin using a rare-earth nanosheet fluorescent probe based on intensity and lifetime signals

A Novel Near-Infrared-Ii Fluorescence Probe for Serum Albumin Biosensing and Site-Binding Mechanism Study

Toxoplasma Gondii and Pre-treatment Protocols for Polymerase Chain Reaction Analysis of Milk Samples: A Field Trial in Sheep from Southern Italy

Understanding selective sensing of human serum albumin using a D–π–A probe: a photophysical and computational approach

Use of piezoelectric-excited millimeter-sized cantilever sensors to measure albumin interaction with self-assembled monolayers of alkanethiols having different functional headgroups

Determination of Albumin and Globulin at Nanogram Levels by a Resonance Light-Scattering Technique with α,β, γ, δ -Tetrakis(4-sulfophenyl)porphine

Rational design of donor-acceptor fluorescent probe for the ratiometric point-of-care testing of human serum albumin

A Rapid and Sensitive Method for the Determination of Trace Proteins Based on the Interaction Between Proteins and Ponceau 4R

Chronopotentiometric Determination of Aluminum by Solochrome Violet RS

Flexible multielectrode arrays based electrochemical aptasensor for glycated human serum albumin detection

Studies on an Immunosensor of Albumin Based on Surface Plasmon Resonance